- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5395 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
Patent holdings for IPC class A61K 31/5395
Total number of patents in this class: 179
10-year publication summary
|
10
|
15
|
8
|
13
|
12
|
17
|
9
|
13
|
5
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bow River LLC | 22 |
15 |
| Bayer AG | 3388 |
8 |
| The Broad Institute, Inc. | 1869 |
8 |
| Principia Biopharma Inc. | 232 |
7 |
| The Regents of the University of California | 20268 |
6 |
| Dana-Farber Cancer Institute, Inc. | 2621 |
5 |
| Abbvie Inc. | 1814 |
4 |
| Eli Lilly and Company | 3911 |
4 |
| BASF SE | 21072 |
3 |
| Bayer Pharma AG | 1049 |
3 |
| Dechra Veterinary Products LLC | 91 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2903 |
3 |
| USpharma Ltd. | 20 |
3 |
| Merck Sharp & Dohme LLC | 3732 |
3 |
| Zevra Denmark A/S | 55 |
3 |
| Merck Sharp & Dohme Corp. | 2190 |
2 |
| Abbott Products GmbH | 9 |
2 |
| University of Florida Research Foundation, Inc. | 4079 |
2 |
| Asahi Kasei Pharma Corporation | 129 |
2 |
| CytRx Corporation | 13 |
2 |
| Other owners | 91 |